• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

    56.24 +2.26 (+4.19%)
    Streaming Delayed Price Updated: 9:47 AM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 239,137
    Open 54.04
    Bid (Size) 56.15 (200)
    Ask (Size) 56.37 (400)
    Prev. Close 53.98
    Today's Range 54.01 - 56.55
    52wk Range 30.04 - 78.48
    Shares Outstanding 78,935,098
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Is CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off? ↗
    The past few years have been challenging for the biotech. 
    Via The Motley Fool
    News headline image
    The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices ↗
    Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now. 
    Via The Motley Fool
    Topics ETFs

    Performance

    YTD
    +4.6%
    +4.6%
    1 Month
    +2.9%
    +2.9%
    3 Month
    +9.7%
    +9.7%
    6 Month
    +3.9%
    +3.9%
    1 Year
    +20.8%
    +20.8%

    More News

    Read More
    News headline image
    2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗
    Via MarketBeat
    News headline image
    Should You Buy Shares of CRISPR Therapeutics in February? ↗
    Via The Motley Fool
    News headline image
    The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026 ↗
    Via The Motley Fool
    News headline image
    Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss) ↗
    Via The Motley Fool
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Forget AI Stocks: This Biotech Could Cure What AI Can't Touch ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Nasdaq, S&P 500 Futures Climb Ahead Of Apple Earnings: Why META, TSLA, MP, CRML, SER Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Government
    News headline image
    Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops ↗
    Via Benzinga
    News headline image
    2 Biotech Stocks That Could Soar This Year ↗
    Via The Motley Fool
    News headline image
    Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    These 2 Healthcare Stocks Beat the Market in 2025. Should You Buy Them in 2026? ↗
    Via The Motley Fool
    News headline image
    The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
    Via PredictStreet
    Topics Economy
    News headline image
    Is CRISPR Therapeutics Stock Yesterday's News? ↗
    Via The Motley Fool
    News headline image
    3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
    Via The Motley Fool
    News headline image
    Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗
    Via The Motley Fool
    News headline image
    2 Growth Stocks to Invest $1,000 in Right Now ↗
    Via The Motley Fool
    News headline image
    From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
    From USA News Group
    Via GlobeNewswire
    News headline image
    2 Monster Stocks in the Making to Buy and Hold ↗
    Via The Motley Fool
    News headline image
    12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    2 Healthcare Stocks to Buy Ahead of the New Year ↗
    Via The Motley Fool
    News headline image
    2 Stocks That Could Soar by 52% and 282%, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
    Via The Motley Fool
    Topics ETFs

    Frequently Asked Questions

    Is CRISPR Therapeutics AG - Common Shares publicly traded?
    Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
    What exchange does CRISPR Therapeutics AG - Common Shares trade on?
    CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
    The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
    What is the current price of CRISPR Therapeutics AG - Common Shares?
    The current price of CRISPR Therapeutics AG - Common Shares is 56.24
    When was CRISPR Therapeutics AG - Common Shares last traded?
    The last trade of CRISPR Therapeutics AG - Common Shares was at 02/24/26 09:47 AM ET
    What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
    The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.44B
    How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
    CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.